Institutional Ownership Aeglea Bio Therapeutics, Inc. (AGLE)
This table provides information about the institutional ownership of Aeglea Bio Therapeutics, Inc. (AGLE). We have compiled data on the 1 institutions that hold shares in the stock, with a total of 240,500 shares, which have been reported (via 13F filing form) to have a value of $6.65 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
240,500
shares
|
$6.65 Million
0.04% of portfolio
|
Q1 2019
New holding
|